Peptide Overview

Definition

Peptides are short chains of amino acids connected by peptide bonds (amide bonds). They are distinguished from proteins primarily by length—conventionally, peptides contain fewer than 50 amino acids, while proteins are larger and often have more complex three-dimensional structures.

The Peptide Bond

The defining feature of a peptide is the peptide bond. It forms when the carboxyl group (–COOH) of one amino acid reacts with the amino group (–NH₂) of another, releasing a water molecule in a condensation reaction.

The resulting –CO–NH– linkage is planar and has partial double-bond character due to resonance, which restricts rotation and influences the conformation of the peptide chain.

Biosynthesis

In living organisms, peptide synthesis occurs on ribosomes during translation (for larger peptides and proteins) or via specialized non-ribosomal peptide synthetases (NRPS) in bacteria and fungi. Ribosomal synthesis follows the genetic code, while NRPS pathways produce many important natural products with non-standard amino acids.

Key Characteristics

• Size: Typically 2–50 amino acids. Dipeptides, tripeptides, and oligopeptides are common terms used.
• Flexibility: Smaller size often allows greater conformational flexibility compared to folded proteins.
• Bioactivity: Many peptides act as hormones, neurotransmitters, or signaling molecules with high potency and specificity.
• Stability: Peptides are generally more susceptible to proteolytic degradation than larger proteins.

Peptides vs. Proteins

While the boundary is somewhat arbitrary, the distinction matters in research and therapeutics:

• Peptides are usually easier to synthesize chemically (solid-phase peptide synthesis).
• They often exhibit rapid onset of action but shorter half-lives in vivo.
• Many therapeutic peptides are designed or modified to improve stability (e.g., cyclization, D-amino acids, PEGylation).

Why Study Peptides?

Peptides bridge the gap between small-molecule drugs and large biologics. Their high target specificity, relatively low toxicity, and the ability to modulate protein–protein interactions make them attractive candidates in drug discovery, diagnostics, and basic biological research.

Key Milestones

• 1902 — Secretin discovered, the first peptide hormone identified.
• 1921 — Insulin isolated, leading to the first peptide-based therapy for diabetes.
• 1953 — Oxytocin synthesized, the first peptide hormone made in the lab.
• 1963 — Bruce Merrifield develops solid-phase peptide synthesis (Nobel Prize 1984).
• 1980s–present — Explosion of therapeutic peptides and peptidomimetics in drug development.